News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
130 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17865)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
2 (104)
3 (173)
4 (173)
5 (128)
6 (1)
7 (23)
8 (258)
9 (151)
10 (98)
11 (90)
12 (52)
13 (1)
14 (1)
15 (70)
16 (158)
17 (130)
18 (132)
19 (69)
20 (4)
21 (3)
22 (130)
23 (153)
24 (124)
25 (141)
26 (79)
27 (1)
28 (1)
29 (133)
30 (155)
31 (147)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Business
Avacta and OncoSec to Collaborate on Innovative Gene Delivery of Therapeutic Affimers
The research programme will evaluate the benefits of delivering Affimer protein genes directly into tumors using the OncoSec technology with the long-term aim of developing gene delivered Affimer immunotherapies.
January 22, 2018
·
3 min read
Genetown
Hologic’s Cynosure Division Launches TempSure Envi
Hologic’s Cynosure division announced today the launch of TempSure Envi - an FDA-cleared advanced radiofrequency device that minimizes facial fine lines and wrinkles, tightens skin through soft tissue coagulation, and improves the appearance of cellulite.
January 22, 2018
·
2 min read
Business
Hangzhou Just Biotherapeutics Opens R&D Center and GMP Manufacturing Facility to Develop Biologic Medicines Globally
Around 200 guests including business partners, investors and representatives from pharmaceutical companies were present to witness this historical moment.
January 22, 2018
·
1 min read
Business
Symic Bio Appoints Hicham Alaoui, Ph.D., as Senior VP of Discovery Biology
With this appointment, Dr. Alaoui will lead research into the identification and characterization of novel therapeutics enabled by the Symic Bio platform.
January 22, 2018
·
2 min read
Drug Development
Pulmatrix Announces Acceptance of a Clinical Trial Application in Europe for Pulmazole - an Inhaled Dry-Powder iSPERSE Formulation of Itraconazole
This phase 1/1b study will be conducted in healthy subjects and patients with mild to moderate stable asthma.
January 22, 2018
·
5 min read
Drug Development
Inovio Pharmaceuticals’ Published Universal Flu Vaccine Data Demonstrates Protective Responses Against All Major, Lethal H1N1 Influenza Viruses From the Last 100 Years in Animal Models
The flu vaccine also affords 100% protection against lethal challenge in the gold standard ferret model, demonstrating the functionality of such broad protective immune responses.
January 22, 2018
·
6 min read
BioCapital
Shimadzu’s LabSolutions Insight Software for LC/MS/MS and GC/MS Provides Powerful Data Mining and Analytics Capabilities
With intuitive operation and a new advanced peak detection algorithm, this software supports review-by-exception to improve the speed and efficiency of multi-analyte data analysis.
January 22, 2018
·
2 min read
ProMIS Neurosciences Issues Response to Recent Market Activity
At the request of IIROC, ProMis Neurosciences wishes to confirm that it is not aware of any material, undisclosed information related to the Company that would account for the recent increase in the market price and level of trading volume of its ordinary shares.
January 22, 2018
·
2 min read
Drug Development
Athenex Announces Encouraging Results of the First Cohort of Phase I Clinical Trial of Oraxol and CYRAMZA (Ramucirumab) Comvric Cancer
A previously completed Phase II clinical trial of Oraxol in the second-line treatment of gastric cancer patients showed an encouraging overall median survival of 10.7 months.
January 22, 2018
·
5 min read
Business
Poxel Announces Fourth Quarter 2017 Financial Update
During the fourth quarter, Poxel generated revenues of €5.2 million ($5.9 million).
January 22, 2018
·
6 min read
Previous
7 of 13
Next